Literature DB >> 7862919

Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.

H Szechtman1, H Talangbayan, G Canaran, H Dai, D Eilam.   

Abstract

The study characterizes the process of sensitization induced by intermittent administrations of quinpirole (0.5 mg/kg) in rats in a large open field. Sensitization was found to be self-limiting, with all measures of behavior reaching a plateau after the tenth twice-weekly injection. Kinetics of sensitization were a simple hyperbolic function of the number of drug injections for some measures (speed of locomotion, length of locomotor bouts) but showed positive co-operativity for others (distance travelled, duration of locomotion, frequency of stops, route stereotypy), suggesting potentiation of the effect by preceding injections. The pace of sensitization varied for different behaviors: locomotor speed changed fastest in the early portion of chronic treatment; stereotypy of route changed primarily during the late phase; mouthing did not sensitize. Sensitization evolved by a cascade of changes that included: advancing the onset of locomotor activation; prolonging the duration of locomotion; establishing new maxima of observable responses; altering the mode of locomotion; raising speed, rate and length of locomotor bouts; and increasing stereotypy of travel. These observations do not substantiate the prediction that development of behavioral sensitization is associated with emergence of disorganized activity and/or fractionation of response chains. Instead, it is proposed that development of sensitization may represent a build-up and strengthening of performance, reflecting enhanced central control of energy expenditure stimulated by repeated injections of quinpirole. Furthermore, it is suggested that for at least one response, the maximum observable amount of locomotion, development of sensitization requires only D2 stimulation, independent of D1 tone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862919     DOI: 10.1007/bf02244757

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Environmental influences on behavioural sensitization to the dopamine agonist quinpirole.

Authors:  P. Willner; M. Papp; S. Cheeta; R. Muscat
Journal:  Behav Pharmacol       Date:  1992-02       Impact factor: 2.293

2.  Home base behavior of rats (Rattus norvegicus) exploring a novel environment.

Authors:  D Eilam; I Golani
Journal:  Behav Brain Res       Date:  1989-09-01       Impact factor: 3.332

3.  Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.

Authors:  J Stewart; P Vezina
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

4.  Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.

Authors:  D Eilam; K V Clements; H Szechtman
Journal:  Behav Brain Res       Date:  1991-11-26       Impact factor: 3.332

5.  Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats.

Authors:  H Einat; H Szechtman
Journal:  Behav Brain Res       Date:  1993-03-31       Impact factor: 3.332

6.  Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.

Authors:  T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic D-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines.

Authors:  D M Camp; T E Robinson
Journal:  Behav Brain Res       Date:  1988-09-01       Impact factor: 3.332

8.  Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.

Authors:  A Imperato; G Tanda; R Frau; G Di Chiara
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

9.  Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains.

Authors:  H Szechtman; K Ornstein; P Teitelbaum; I Golani
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

10.  Central dopaminergic activity influences rats ability to exercise.

Authors:  M P Heyes; E S Garnett; G Coates
Journal:  Life Sci       Date:  1985-02-18       Impact factor: 5.037

View more
  18 in total

1.  Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).

Authors:  Mark C Tucci; Anna Dvorkin-Gheva; Renee Sharma; Leena Taji; Paul Cheon; John Peel; Ashley Kirk; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.

Authors:  Anna Dvorkin; Kirsten E Culver; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2006-05-11       Impact factor: 4.530

Review 3.  Obsessive-compulsive disorder: Insights from animal models.

Authors:  Henry Szechtman; Susanne E Ahmari; Richard J Beninger; David Eilam; Brian H Harvey; Henriette Edemann-Callesen; Christine Winter
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

4.  Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole.

Authors:  H Einat; D Einat; M Allan; H Talangbayan; T Tsafnat; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.

Authors:  B A Mattingly; S E Fields; M S Langfels; J K Rowlett; P M Robinet; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

6.  Effects of dopamine D2 agonist quinpirole on neuronal activity of anterior cingulate cortex and striatum in rats.

Authors:  Jian-Jia Huang; Chen-Tung Yen; Tzu-Lan Liu; Hen-Wai Tsao; Ju-Wei Hsu; Meng-Li Tsai
Journal:  Psychopharmacology (Berl)       Date:  2013-01-18       Impact factor: 4.530

7.  Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling.

Authors:  Shuichi Chiba; Tadahiro Numakawa; Midori Ninomiya; Hyung Shin Yoon; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

8.  Social spatial cognition: social distance dynamics as an identifier of social interactions.

Authors:  Alex Dorfman; David Eilam
Journal:  Anim Cogn       Date:  2020-10-13       Impact factor: 3.084

9.  Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.

Authors:  H Szechtman; M J Eckert; W S Tse; J T Boersma; C A Bonura; J Z McClelland; K E Culver; D Eilam
Journal:  BMC Neurosci       Date:  2001-04-12       Impact factor: 3.288

10.  Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.

Authors:  Melissa L Perreault; Dawn Graham; Sarah Scattolon; Yufang Wang; Henry Szechtman; Jane A Foster
Journal:  Psychopharmacology (Berl)       Date:  2007-07-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.